Home LiteratureArticle Details
PMID: 15564505 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes.

Journal of virology ·Vol. 78 ·No. 24 ·2004-12-00 ·Pages 13975-86

Crill WD, Chang GJ

Abstract

The flavivirus E glycoprotein, the primary antigen that induces protective immunity, is essential for membrane fusion and mediates binding to cellular receptors. Human flavivirus infections stimulate virus species-specific as well as flavivirus cross-reactive immune responses. Flavivirus cross-reactive antibodies in human sera create a serious problem for serodiagnosis, especially for secondary flavivirus infections, due to the difficulty of differentiating primary from secondary cross-reactive serum antibodies. The presence of subneutralizing levels of flavivirus cross-reactive serum antibodies may result in a dramatic increase in the severity of secondary flavivirus infections via antibody-dependent enhancement. An understanding of flavivirus E-glycoprotein cross-reactive epitopes is therefore critical for improving public health responses to these serious diseases. We identified six E-glycoprotein residues that are incorporated into three distinct flavivirus cross-reactive epitopes. Two of these epitopes which are recognized by distinct monoclonal antibodies contain overlapping continuous residues located within the highly conserved fusion peptide. The third epitope consists of discontinuous residues that are structurally related to the strictly conserved tryptophan at dengue virus serotype 2 E-glycoprotein position 231.

MeSH Terms
Amino Acid Sequence Animals Antibodies, Viral/immunology CHO Cells COS Cells Chlorocebus aethiops Cricetinae Cricetulus Cross Reactions Dengue Virus/immunology,metabolism Epitope Mapping Epitopes/immunology Models, Molecular Molecular Sequence Data Mutagenesis, Site-Directed Viral Envelope Proteins/chemistry,immunology
Chemicals
Antibodies, Viral Epitopes Viral Envelope Proteins prM protein, Flavivirus glycoprotein E, Flavivirus
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Crill Wayne D
Arbovirus Diseases Branch, Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, U.S. Department of Health and Human Services, P.O. Box 2087, Fort Collins, CO 80522, USA. wcrill@cdc.gov.
Chang Gwong-Jen J
References (50)
50 references, click to expand
  1. X-ray snapshots of the maturation of an antibody response to a protein antigen.
    Nat Struct Biol. 2003 Jun;10(6):482-8 PMID: 12740607
  2. Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice.
    J Virol. 1993 Aug;67(8):4956-63 PMID: 8331735
  3. Antibody-dependent enhancement of Murray Valley encephalitis virus virulence in mice.
    J Gen Virol. 2003 Jul;84(Pt 7):1723-8 PMID: 12810865
  4. Questions on viral population biology to complete dengue puzzle.
    Trends Microbiol. 2003 Sep;11(9):415-21 PMID: 13678856
  5. Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications.
    Rev Med Virol. 2003 Nov-Dec;13(6):387-98 PMID: 14625886
  6. Recent advancement in flavivirus vaccine development.
    Expert Rev Vaccines. 2004 Apr;3(2):199-220 PMID: 15056045
  7. Protection against West Nile virus induced by a previous injection with dengue virus.
    Am J Epidemiol. 1971 Dec;94(6):596-607 PMID: 5133787
  8. Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies.
    Am J Trop Med Hyg. 1982 May;31(3 Pt 1):548-55 PMID: 6177259
  9. Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies.
    Am J Trop Med Hyg. 1985 Jan;34(1):162-9 PMID: 2578750
  10. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution.
    Science. 1985 Aug 23;229(4715):726-33 PMID: 4023707
  11. Pathogenesis of dengue: challenges to molecular biology.
    Science. 1988 Jan 29;239(4839):476-81 PMID: 3277268
  12. Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model.
    J Virol. 1989 Feb;63(2):564-71 PMID: 2463377
  13. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera.
    J Gen Virol. 1989 Jan;70 ( Pt 1):37-43 PMID: 2543738
  14. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade.
    Rev Infect Dis. 1989 May-Jun;11 Suppl 4:S830-9 PMID: 2665015
  15. Serologically defined linear epitopes in the envelope protein of dengue 2 (Jamaica strain 1409).
    Arch Virol. 1989;105(3-4):209-21 PMID: 2473720
  16. A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice.
    J Virol. 2000 May;74(9):4244-52 PMID: 10756038
  17. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
    Biochemistry. 2000 May 30;39(21):6296-309 PMID: 10828942
  18. Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein.
    J Virol. 2001 Apr;75(8):4002-7 PMID: 11264392
  19. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays.
    J Virol. 2001 May;75(9):4040-7 PMID: 11287553
  20. Mutational evidence for an internal fusion peptide in flavivirus envelope protein E.
    J Virol. 2001 May;75(9):4268-75 PMID: 11287576
  21. Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers.
    Vaccine. 2001 Apr 30;19(23-24):3179-88 PMID: 11312014
  22. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells.
    J Virol. 2001 Aug;75(16):7769-73 PMID: 11462053
  23. A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen.
    J Virol Methods. 2001 Sep;97(1-2):133-49 PMID: 11483224
  24. Dengue and other emerging flaviviruses.
    J Infect. 2001 Feb;42(2):104-15 PMID: 11531316
  25. The 1.85 A resolution crystal structures of tissue factor in complex with humanized Fab D3h44 and of free humanized Fab D3h44: revisiting the solvation of antigen combining sites.
    J Mol Biol. 2001 Oct 12;313(1):83-97 PMID: 11601848
  26. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century.
    Trends Microbiol. 2002 Feb;10(2):100-3 PMID: 11827812
  27. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion.
    Cell. 2002 Mar 8;108(5):717-25 PMID: 11893341
  28. Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis.
    Emerg Infect Dis. 2002 Mar;8(3):245-51 PMID: 11927020
  29. Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations.
    J Mol Biol. 2002 Jul 5;320(2):369-87 PMID: 12079393
  30. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.
    Virology. 2002 Jun 20;298(1):146-59 PMID: 12093182
  31. Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses.
    Am J Trop Med Hyg. 2002 Mar;66(3):264-72 PMID: 12139219
  32. Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever.
    Lancet. 2002 Jul 27;360(9329):310-2 PMID: 12147378
  33. Molecular basis of crossreactivity and the limits of antibody-antigen complementarity.
    Nature. 1993 Oct 28;365(6449):859-63 PMID: 8413674
  34. Bound water molecules and conformational stabilization help mediate an antigen-antibody association.
    Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):1089-93 PMID: 8302837
  35. Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH.
    J Virol. 1995 Feb;69(2):695-700 PMID: 7529335
  36. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution.
    Nature. 1995 May 25;375(6529):291-8 PMID: 7753193
  37. Interactions of protein antigens with antibodies.
    Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):7-12 PMID: 8552677
  38. Phylogeny of the genus Flavivirus.
    J Virol. 1998 Jan;72(1):73-83 PMID: 9420202
  39. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling.
    Electrophoresis. 1997 Dec;18(15):2714-23 PMID: 9504803
  40. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
    Virology. 1998 Jul 5;246(2):317-28 PMID: 9657950
  41. Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution.
    J Mol Biol. 1998 Aug 14;281(2):301-22 PMID: 9698550
  42. The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens.
    Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):790-4 PMID: 9892712
  43. The atomic structure of protein-protein recognition sites.
    J Mol Biol. 1999 Feb 5;285(5):2177-98 PMID: 9925793
  44. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site.
    Nat Struct Biol. 1999 Jun;6(6):530-4 PMID: 10360354
  45. Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E.
    J Virol. 1999 Jul;73(7):5605-12 PMID: 10364309
  46. Research on dengue during World War II.
    Am J Trop Med Hyg. 1952 Jan;1(1):30-50 PMID: 14903434
  47. Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus.
    Virology. 2003 Feb 1;306(1):170-80 PMID: 12620809
  48. Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein.
    Virology. 1992 Apr;187(2):480-91 PMID: 1372140
  49. Two-way cross-protection between West Nile and Japanese encephalitis viruses in bonnet macaques.
    Acta Virol. 1992 May;36(3):277-83 PMID: 1360756
  50. A ligand-binding pocket in the dengue virus envelope glycoprotein.
    Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):6986-91 PMID: 12759475
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2004-12-00
Pages
13975-86
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC533943
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com